CYTK
Price
$30.95
Change
-$0.29 (-0.93%)
Updated
Sep 22, 6:59 PM EST
39 days until earnings call
IMPL
Price
$0.54
Change
+$0.01 (+1.89%)
Updated
Sep 22, 6:59 PM EST
51 days until earnings call

Compare predictions CYTK vs IMPL

Header iconCYTK vs IMPL Comparison
Open Charts CYTK vs IMPLBanner chart's image
Cytokinetics
Price$30.95
Change-$0.29 (-0.93%)
Volume$252.83K
CapitalizationN/A
Impel Pharmaceuticals
Price$0.54
Change+$0.01 (+1.89%)
Volume$36K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs IMPL Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CYTK vs. IMPL commentary
Sep 24, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and IMPL is a Hold.

COMPARISON
Comparison
Sep 24, 2023
Stock price -- (CYTK: $30.95 vs. IMPL: $0.55)
Brand notoriety: CYTK and IMPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 57% vs. IMPL: 6%
Market capitalization -- CYTK: $2.97B vs. IMPL: $13.06M
CYTK [@Biotechnology] is valued at $2.97B. IMPL’s [@Biotechnology] market capitalization is $13.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileIMPL’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • IMPL’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than IMPL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 5 TA indicator(s) are bullish while IMPL’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 5 bullish, 5 bearish.
  • IMPL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMPL is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -9.58% price change this week, while IMPL (@Biotechnology) price change was -13.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

CYTK is expected to report earnings on Nov 02, 2023.

IMPL is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for IMPL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($2.97B) has a higher market cap than IMPL($12.9M). CYTK YTD gains are higher at: -32.453 vs. IMPL (-85.333). IMPL has higher annual earnings (EBITDA): -77.72M vs. CYTK (-474.2M). CYTK has more cash in the bank: 566M vs. IMPL (15.2M). IMPL has less debt than CYTK: IMPL (52.3M) vs CYTK (749M). IMPL has higher revenues than CYTK: IMPL (19M) vs CYTK (9.95M).
CYTKIMPLCYTK / IMPL
Capitalization2.97B12.9M23,031%
EBITDA-474.2M-77.72M610%
Gain YTD-32.453-85.33338%
P/E RatioN/AN/A-
Revenue9.95M19M52%
Total Cash566M15.2M3,724%
Total Debt749M52.3M1,432%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKIMPL
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RAYA1.220.05
+4.27%
Erayak Power Solution Group
SFBS49.470.02
+0.04%
ServisFirst Bancshares
KURA8.86-0.17
-1.88%
Kura Oncology
TSQ9.03-0.22
-2.38%
Townsquare Media
CUK12.69-0.38
-2.91%
Carnival PLC

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.93%
TVTX - CYTK
57%
Loosely correlated
+2.75%
ARWR - CYTK
56%
Loosely correlated
+0.04%
ALEC - CYTK
51%
Loosely correlated
+14.10%
SANA - CYTK
51%
Loosely correlated
-3.28%
PTCT - CYTK
50%
Loosely correlated
-3.63%
More